Safety Alerts Saves Lives
Safety Alerts  
 
Home Privacy About Us Contact Us Change Preferences

SafetyAlerts
July 25, 2000

JPI Jones Daniels Pharmaceuticals Levoxyl Recalled

St. Louis, MO (SafetyAlerts) - The Food and Drug Administration (FDA) today reported that Jones Pharma, Inc. is conducting a recall of JPI Jones Daniels Pharmaceuticals Levoxyl because the milligram conversion on the unit blisters is incorrectly declared as 0.75 mg.

PRODUCT
JPI Jones Daniels Pharmaceuticals Levoxyl (Levothyroxine Sodium Tablets), 75 mcg (0.075 mg), Rx, packaged in unit-dose strips 10/10-tablet strips per box.

Recall #D-434-0.  Class III

CODE
Lot #6221 EXP 02/01.

MANUFACTURER
Daniels Pharmaceuticals, St. Petersburg, Florida.

RECALLED BY
Jones Pharma, Inc., St. Louis, Missouri, by telephone on May 8, 2000. Firm-initiated recall ongoing.  This is the first public notice issued by the FDA.

DISTRIBUTION
Nationwide.

QUANTITY
440 10/10-tablet strip boxes were distributed.

Questions concerning this recall may be directed to the FDA at 1-888-INFO-FDA.

Notice of this product warning was sent via email to SafeMail subscribers July 25, 2000.

 
Selected Recent Recalls


Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

Safety Alerts compiles comprehensive safety recall information for the United States. SafeMail is a free email service to warn consumers of faulty products and contaminated foods. For complete information regarding current recalls, past recalls and timely product warning notification visit: www.safetyalerts.com.

###

 

The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.